3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Carcinoma, Non-Small-Cell Lung
13
Urinary Bladder Neoplasms
12
Neoplasms
10
Carcinoma, Renal Cell
9
Ovarian Neoplasms
7
Carcinoma, Transitional Cell
7
Neoplasm Metastasis
6
Pancreatic Neoplasms
5
Breast Neoplasms
5
Squamous Cell Carcinoma of Head and Neck
4
Carcinoma, Merkel Cell
4
Triple Negative Breast Neoplasms
3
Recurrence
3
Lymphoma
3
Lung Neoplasms
3
Fallopian Tube Neoplasms
3
Colorectal Neoplasms
3
Stomach Neoplasms
2
Prostatic Neoplasms
2
Melanoma
2
Leukemia, Myeloid, Acute
2
Kidney Neoplasms
2
Kidney Diseases
2
Carcinoma, Ovarian Epithelial
2
Carcinoma, Hepatocellular
2
Urothelial Cancer
1
Urologic Neoplasms
1
Urethral Neoplasms
1
Ureteral Neoplasms
1
Turcot syndrome
1
Interventions
pazopanib
5
Doxorubicin
3
Bevacizumab
3
carotuximab
2
Sorafenib
2
Radiotherapy, Conformal
2
Paclitaxel
2
Gemcitabine
2
tremelimumab
1
trebananib
1
temsirolimus
1
talimogene laherparepvec
1
romidepsin
1
regorafenib
1
indolepropanol phosphate
1
eribulin
1
durvalumab
1
cixutumumab
1
Watchful Waiting
1
Vascular Endothelial Growth Factor A
1
TTI-621
1
Sunitinib
1
Sirolimus
1
Razoxane
1
Observation
1
Magnetic Resonance Spectroscopy
1
Ifosfamide
1
HhAntag691
1
Fluorodeoxyglucose F18
1
Docetaxel
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Has results
×
Hemangiosarcoma
×
avelumab
×
Clear all
No trials found.